Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036.
Article
PubMed
Google Scholar
Terashima M, Maesawa C, Oyama K, Ohtani S, Akiyama Y, Ogasawara S, et al. Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Brit J Cancer. 2005;92(6):1130.
Article
CAS
PubMed
Google Scholar
Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 2015;149(5):1153–62.
Article
CAS
PubMed
Google Scholar
Cervantes A, Braun ER, Fidalgo AP, González IC. Molecular biology of gastric cancer. Clin Transl Oncol. 2007;9(4):208–15.
Article
CAS
PubMed
Google Scholar
Fan XY, Hu XL, Han TM, Wang NN, Zhu YM, Hu W, et al. Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis. BMC Gastroenterol. 2011;11(1):92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang Y, Zhou X, Jin Y. ADAR-mediated RNA editing in non-coding RNA sequences. Sci China Life Sci. 2013;56(10):944–52.
Article
CAS
PubMed
Google Scholar
Gal-Mark N, Shallev L, Sweetat S, Barak M, Li JB, Levanon EY, et al. Abnormalities in A-to-I RNA editing patterns in CNS injuries correlate with dynamic changes in cell type composition. Sci Rep. 2017;7(1):1–12.
Article
Google Scholar
Xu LD, Öhman M. ADAR1 editing and its role in Cancer. Genes. 2019;10(1):12.
Article
CAS
Google Scholar
Deffit SN, Hundley HA. To edit or not to edit: regulation of ADAR editing specificity and efficiency. WIREs RNA. 2016;7(1):113–27.
Article
CAS
PubMed
Google Scholar
Kung CP, Maggi LB Jr, Weber JD. The role of RNA editing in cancer development and metabolic disorders. Front Endocrinol. 2018;9:762.
Article
Google Scholar
Zhang Y, Qian H, Xu J, Gao W. ADAR, the carcinogenesis mechanisms of ADAR and related clinical applications. Ann Transl Med. 2019;7(22):686.
Article
PubMed
PubMed Central
CAS
Google Scholar
Herbert A. ADAR and immune silencing in Cancer. Trends Cancer. 2019;5(5):272–82.
Article
CAS
PubMed
Google Scholar
Amin EM, Liu Y, Deng S, Tan KS, Chudgar N, Mayo MW, et al. The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK. Sci Signal. 2017;10(497):eaah3941.
Article
PubMed
PubMed Central
CAS
Google Scholar
Fritzell K, Xu LD, Otrocka M, Andréasson C, Öhman M. Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries. Nucleic Acids Res. 2018;47(4):e22.
Article
PubMed Central
CAS
Google Scholar
Gershenwald J, Scolyer R, Hess K, Thompson J, Long G, Ross M, et al. AJCC cancer staging manual. Switzerland: Springer; 2017. p. 563–89.
Book
Google Scholar
McCord BR, Butler JM. The application of capillary electrophoresis in the analysis of PCR products used in genetic typing. New Jersey: Humana Press; 2001. p. 261–84.
Google Scholar
Gay-Bellile M, Romero P, Cayre A, Véronèse L, Privat M, Singh S, et al. ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis. J Pathol Clin Res. 2016;2(4):203–20.
Article
CAS
Google Scholar
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603.
Article
CAS
PubMed
PubMed Central
Google Scholar
Szász AM, Lánczky A, Nagy Á, Förster S, Hark K, Green JE, et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget. 2016;7(31):49322–33.
Article
PubMed
PubMed Central
Google Scholar
Zheng Q, Wu F, Dai WY, Zheng DC, Zheng C, Ye H, et al. Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol. 2015;17(8):640–6.
Article
CAS
PubMed
Google Scholar
Liu J, Liu Z, Zhang X, Gong T, Yao D. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools. BMC Cancer. 2019;19(1):227.
Article
PubMed
PubMed Central
CAS
Google Scholar
Okugawa Y, Toiyama Y, Shigeyasu K, Yamamoto A, Shigemori T, Yin C, et al. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer. J Transl Med. 2018;16(1):366.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu X, Wan S, Ou Y, Zhou B, Zhu J, Yi X, et al. RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing. Cancer Lett. 2015;357(2):510–9.
Article
CAS
PubMed
Google Scholar
Chen Y, Wang H, Lin W, Shuai P. ADAR1 overexpression is associated with cervical cancer progression and angiogenesis. Diagn Pathol. 2017;12(1):12.
Article
PubMed
PubMed Central
CAS
Google Scholar
Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, et al. Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep. 2015;13(2):267–76.
Article
CAS
PubMed
Google Scholar
Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 2002;62(21):6240–5.
CAS
PubMed
Google Scholar
Dou N, Yu S, Ye X, Yang D, Li Y, Gao Y. Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling. Oncotarget. 2016;7(52):86161–73.
Article
PubMed
PubMed Central
Google Scholar
Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med. 2013;19(2):209–16.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shigeyasu K, Okugawa Y, Toden S, Miyoshi J, Toiyama Y, Nagasaka T, et al. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer. JCI insight. 2018;3(12):e99976.
Article
PubMed Central
Google Scholar
Han J, Tu J, Tang C, Ma X, Huang C. Clinicopathological characteristics and prognosis of cT1N0M1 gastric Cancer: a population-based study. Dis Markers. 2019;2019:5902091.
Article
PubMed
PubMed Central
Google Scholar
Chan TH, Qamra A, Tan KT, Guo J, Yang H, Qi L, et al. ADAR-mediated RNA editing predicts progression and prognosis of gastric cancer. Gastroenterology. 2016;151(4):637–50.
Article
CAS
PubMed
Google Scholar